Fullscreen
CYTOPATHNET: Online Resource for Cytopathology > Brief Overview
page id: 94 2006 ASCCP Clinical Management Guidelines for Cervical Intraepithelial Neoplasia or Adenocarcinoma in Situ (Cached) Status > ToDo Guidelines > GYN Practice Guidelines Publication
3d browser Refresh Print

Brief Overview

exclaim THIS PAGE NEEDS EDITING FOR CIN AND AIS GUIDELINES

 

exclaim Evidence-based consensus guidelines for the clinical management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ were recently developed and published by a multidisciplinary group. This group met on September 18-19, 2006 in Bethesda, Maryland, and consisted of 149 experts and 29 organizations and professional societies. The guidelines were officially released on October 5, 2007.

 

Brief Overview

 

What has Changed?
What has Changed?
CategoryType of Change
CIN 1 Significant changes. Treatment discouraged for adolescents.
CIN 2-3 Minor modifications. Management for adolescents expanded.
AIS New-guidelines now included

 

The Specifics

How the Recommendations Were Rated
Rating the recommendations
Strength of RecommendationDescription
A Good evidence for efficacy and substantial clinical benefit support recommendation for use.
B Moderate evidence for efficacy or only limited clinical benefit supports recommendation for use.
C Evidence for efficacy is insufficient to support a recommendation for or against use, but recommendations may be made on other
grounds.
D Moderate evidence for lack of efficacy or for adverse outcome supports a recommendation against use.
E Good evidence for lack of efficacy or for adverse outcome supports a recommendation against use.
Quality of Evidence*Description
I Evidence from at least 1 randomized, controlled trial.
II Evidence from at least 1 clinical trial without randomization, from cohort or case-controlled analytic studies (preferably from more than
1 center) or from multiple time-series studies or dramatic results from uncontrolled experiments.
III Evidence from opinions of respected authorities based on clinical experience, descriptive studies, or reports of expert committees.
Terminology used for recommendations†Description
Recommended Good data to support use when only 1 option is available.
Preferred Option is the best (or 1 of the best) when there are multiple other options
Acceptable One of multiple options when there are either data indicating that another approach is superior or when there are no
data to favor any single option.
Unacceptable Good data against use.
  • Modified from references 1.

† The assignment of these terms represents an opinion ratified by vote by the Consensus Conference.

CIN 1
CIN 2-3
AIS

 

2001 ASCCP Guidelines

2001 ASCCP Guidelines are linked here for reference.

References

 
1. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
Thomas C. Wright , L. Stewart Massad , Charles J. Dunton , Mark Spitzer , Edward J. Wilkinson , Diane Solomon
American Journal of Obstetrics & Gynecology- 2007 October (Vol. 197, Issue 4, Pages 346-355, DOI: 10.1016/j.ajog.2007.07.047(external link)) NOTE: For access to article without fee, choose Article via Elsevier Health Sciences - Elsevier imprints, theclinics.com, and ophsource.org .

2. The 2001 Consensus Guidelines for the Management of Women with Cytological Abnormalities. JAMA (2002;287:2120-2129)(external link). American Society for Colposcopy and Cervical Pathology (ASCCP)


Contributors to this page: admin .
Page last modified on Saturday 17 of November, 2007 00:54:05 MST by admin.
The content on this page is licensed under the terms of the Creative Commons Attribution-ShareAlike License.

Search Wiki Page

Exact match

CYTOPATHNET Polls

Do you plan to adopt the Bethesda Guidelines for Thyroid Cytology?






Code of Conduct

We comply with the HONcode standard for health trust worthy information:
verify here.

Theme: Tikinewt

TikiWiki assistant

Thank you for installing Tikiwiki!

LoginTo begin configuring Tiki, please login as admin.

The Tikiwiki CommunityTo learn more, visit: http://tiki.org.

Tikiwiki DocumentationFor help, visit http://doc.tiki.org.

Upcoming events

1)  Thu 01 of Nov., 2012
ASC 60th Annual Meeting-Las Vegas
2)  Sun 12 of May, 2013
National Cytotechnology Day

Online users

76 online users

Search PubMed

PubMed Logo
Search PubMed:   

Shoutbox

admin, 21:24 MST, Wed 22 of Feb., 2012: User registration enhancements made and more coming in future.
admin, 18:06 MST, Sun 29 of Jan., 2012: Site upgraded from 6.4 to 6.6.
admin, 21:56 MDT, Thu 06 of Oct., 2011: Not sure I totally understand question. Perhaps post to forums for feedback.
savco68 points , 08:04 MDT, Wed 21 of Sep., 2011: if you do breast FNA and interpret as adequate but you do 2 pass and put it straight for CB would you bill for it ?
admin, 10:49 MST, Sat 22 of Jan., 2011: Posted 2011 "President's Message". [Link]

Last blog posts

  1. The Populiist Cytologist Has Moved- Come Join Me!
    Thu 05 of Apr., 2012 05:59 MDT
  2. Full Circle-A Brief Reflection on Technology...And Life in General
    Mon 12 of Sep., 2011 23:57 MDT
  3. Another Year of Testing--Done!
    Wed 17 of Nov., 2010 20:08 MST
  4. AMA - Publishes Guidelines for Physicians for Social Media Use
    Mon 15 of Nov., 2010 19:48 MST
  5. Video Tutorials
    Sun 02 of May, 2010 00:38 MDT
  6. Cloud Computing and Web 2.0
    Mon 23 of Nov., 2009 11:15 MST
  7. Social Networking
    Sat 11 of Apr., 2009 12:10 MDT
  8. CYTOPATHNET Group on Facebook!
    Wed 08 of Apr., 2009 21:03 MDT
  9. Site Move Completed!
    Sat 09 of Aug., 2008 16:44 MDT
  10. Blueprint for the Future
    Sun 29 of June, 2008 10:40 MDT

Random Image

thumbnail
abw.jpg
Gallery: Breast Cytology

Google Search

 
www.cytopathnet.org
WWW

Site Language: English